# OnCo record foresight-diagnostics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/foresight-diagnostics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "foresight-diagnostics" ;
  schema:name "Foresight Diagnostics"@en ;
  schema:description "Stanford spin-out whose PhasED-Seq ctDNA technology detects residual lymphoma more accurately than PET/CT; clinical launch of CLARITY in 2026."@en ;
  schema:url <https://onco.cc/companies/foresight-diagnostics/>, <https://foresight-dx.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://foresight-dx.com/foresight-products-services/foresight-clarity/> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:terms <https://onco.cc/terms/mrd/> ;
  onco:trials <https://onco.cc/trials/nct06500273/> .